. 2023 Feb 9;9:e41404. doi: 10.2196/41404

Table 4.

OR^a estimates related to admission to the hospital among those who tested positive for SARS-CoV-2 (N=4644), stratified by gender and age group (1 model for each variable).

Variable and category		Male		Female
		Age 45-59 years (n=1101, 23.7%), OR (95% CI)^b	Age 60-74 years (n=1974, 42.5%), OR (95% CI)^b	Age 45-59 years (n=616, 13.3%), OR (95% CI)^b	Age 60-74 years (n=953, 20.5%), OR (95% CI)^b
CCI^c
	0	Reference	Reference	Reference	Reference
	1	1.50 (1.20-1.88)^d	1.51 (1.23-1.84)^d	1.50 (1.20-1.88)^d	1.22 (0.98-1.52)
	2-3	2.14 (1.51-3.01)^d	1.40 (1.12-1.75)^d	2.49 (1.77-3.50)^d	2.28 (1.74-2.99)^d
	4+	4.77 (2.28-9.99)^d	1.98 (1.41-2.78)^d	2.45 (0.86-6.94)	4.22 (2.56-6.97)^d
Oncological disease		2.62 (1.52-4.51)^d	1.27 (0.93-1.73)	2.26 (1.39-3.68)^d	1.97 (1.34-2.92)^d
Cardiovascular disease		1.53 (1.13-2.08)^d	1.30 (1.01-1.49)^d	1.69 (1.17-2.44)^d	1.52 (1.19-1.95)^d
Respiratory disease		2.17 (1.48-3.19)^d	1.47 (1.12-1.92)^d	2.13 (1.31-3.45)^d	2.16 (1.57-2.96)^d
Myocardial infarction		1.84 (1.03-3.30)^d	1.47 (1.09-1.97)^d	2.05 (0.61-6.94)	2.36 (1.44-3.89)^d
Heart failure		7.90 (1.53-40.70)^d	2.18 (1.23-3.86)^d	1.25 (0.12-12.56)	1.88 (0.90-3.93)
Cerebrovascular disease		1.39 (0.69-2.81)	0.92 (0.68-1.26)	1.30 (0.47-3.63)	1.11 (0.73-1.71)
Diabetes		1.65 (1.20-2.28)^d	1.61 (1.31-1.96)^d	1.89 (1.35-2.63)^d	2.10 (1.64-2.69)^d

^aOR: odds ratio.

^bEstimates adjusted for age and the month of the first swab.

^cCCI: Charlson Comorbidity Index.

^dSignificant estimates (95% confidence level).